Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3000 participants.

Also called NCT02534545

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 3,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02534545
Other papers using this trial's data
  • Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China The Lancet. Neurology, 2022-12 DOI, PubMed 36354026

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02534545. Randomized; quadruple masking; primary purpose prevention. Start 2015-10 (actual); primary completion 2019-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Remote Ischemic Conditioning for Avoiding Recurrence of Symptomatic Intracranial Atherosclerotic Stenosis (sICAS)
Condition
Intracranial Atherosclerosis
Intervention (Device)
Doctormate® (200mmHg)
Intervention (Device)
Doctormate® (60mmHg)
Lead sponsor
Ji Xunming,MD,PhD (class: other)

Record details

Record id
cardio:ct-nct02534545
Content hash
ad6fe6acb2545560d986af59bdc563d1c7b091c5985cfc503087d893df89e661